STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
2022 · Neuro-Oncology · 29 citations
https://doi.org/10.1093/neuonc/noac093
J
Jizhi Ge
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
39
Citations
2
h-index
1
i10-index
Jizhi Ge is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Nanoparticle-Based Drug Delivery & Drug Transport and Resistance Mechanisms. The author has an h-index of 2, co-authored 10 publications.
Papers by this author
works266 Combination Drug Therapy in H3 K27-Altered Diffuse Midline Glioma Enhances Tumor Retention and Treatment Efficacy
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_266
Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma
2026 · Communications Biology · 0 citations
https://doi.org/10.1038/s42003-025-09155-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat